HomeNew c-Met Inhibitors

New c-Met Inhibitors

Catalog No. Product Name Information
F0288 Met Antibody [L21L21] c-Met,Met,Met (c-Met)
A4000 Amivantamab (Anti-cMet & EGFR) Amivantamab is a fully human bispecific antibody that targets both epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET). It exhibits immune anticancer activity in non-small cell lung cancer (NSCLC). MW :145.88 KD.
≡ All c-Met Inhibitors